CSIMarket
 
Penumbra Inc  (PEN)
Other Ticker:  
 

Penumbra Inc

Officers & Directors


1. Adam Elsesser - President and CEO of Penumbra Inc.
A former executive at Boston Scientific and Intuitive Surgical, Elsesser joined Penumbra in 2005 as Vice President of Corporate Development and has since taken on increasing levels of responsibility.

2. Sridhar Kosaraju - Chief Financial Officer
Kosaraju joined Penumbra in 2015 after working as a management consultant for McKinsey & Company.

3. Robert D. Evans - Chairman of the Board of Directors
Evans has served as Chairman of the Board since 2016 and as a director since 2006. He previously held executive positions at Guidant Corporation and Boston Scientific.

4. Bridget O'Rourke - Vice President, Regulatory Affairs
O'Rourke joined Penumbra in 2014 and has over 20 years of experience in regulatory affairs and quality assurance in the medical device industry.

5. Thomas Wilder - Vice President of Clinical Affairs
Wilder has been with Penumbra since 2013 and has over 20 years of experience in clinical research and medical device development.



Penumbra Inc currently has 2600 employees.






PEN Management Effectiveness PEN Revenue per Employee PEN Income per Employee


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com